Literature DB >> 32180141

Tumor-infiltrating regulatory T cells, CD8/Treg ratio, and cancer stem cells are correlated with lymph node metastasis in patients with early breast cancer.

Luis Alberto Solis-Castillo1, Gina Stella Garcia-Romo2,3, Alvaro Diaz-Rodriguez2, Diana Reyes-Hernandez2, Elizabeth Tellez-Rivera2, Victor Hugo Rosales-Garcia4, Adolfo Rene Mendez-Cruz3, Jose Rafael Jimenez-Flores2,3, Victor Hugo Villafana-Vazquez1, Alexander Pedroza-Gonzalez5,6,7.   

Abstract

BACKGROUND: Tumor-infiltrating lymphocytes are an important component of the tumor microenvironment (TME) in breast cancer. They have been linked with tumor pathogenesis in advanced stages. However, little is known about their contribution in early phases. In this study, we analyzed the infiltration of leukocytes and cancer stem cells (CSC) in tumors from patients with early breast cancer.
METHODS: Samples of blood and tumor tissue from 30 patients with breast cancer were collected, and the number of dendritic cells (DC), T cells, and CSC were analyzed by flow cytometry.
RESULTS: Tumor-infiltrating CD4 and CD8 T cells expressed higher levels of cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) compared with peripheral T cells. Regulatory T cells (Treg) were enriched in tumors and overexpressed glucocorticoid-induced TNFR-related protein and CTLA-4. Tumor Treg had a positive correlation with the amount of myeloid DC (mDC) and disease progression. The CD8/Treg ratio was associated with lymph node metastasis and tumor stages. The main subset of DC in early breast tumors was mDC, while plasmacytoid DC were almost absent. CSC were present in most tumors with higher frequencies in patients with lymph node metastasis. CSC were also associated with the amount of tumor-infiltrating Treg.
CONCLUSION: Early breast cancer has an inflammatory milieu characterized by mDC, Treg, and CSC infiltration. The frequencies of Treg, CSC and CD8/Treg ratio were associated with disease progression. The composition of leukocytes and the presence of CSC in early breast tumors should be considered for the development of new therapeutic approaches.

Entities:  

Keywords:  Cancer stem cells; Dendritic cells; Early breast cancer; Regulatory T cells

Year:  2020        PMID: 32180141     DOI: 10.1007/s12282-020-01079-y

Source DB:  PubMed          Journal:  Breast Cancer        ISSN: 1340-6868            Impact factor:   4.239


  16 in total

1.  Regulatory T Cells: Concept, Classification, Phenotype, and Biological Characteristics.

Authors:  Yang Du; Qiannan Fang; Song-Guo Zheng
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Effects of Dezocine and Sufentanil on Th1/Th2 Balance in Breast Cancer Patients Undergoing Surgery.

Authors:  Xudong Hu; Bing Luo; Qing Wu; Qingbiao Chen; Penghui Lu; Jie Huang; Xiaoxia Liang; Cheng Ling; Yiqun Li
Journal:  Drug Des Devel Ther       Date:  2021-12-02       Impact factor: 4.162

Review 3.  Prognostic and therapeutic role of tumor-infiltrating lymphocyte subtypes in breast cancer.

Authors:  Molly A Nelson; Worapol Ngamcherdtrakul; Shiuh-Wen Luoh; Wassana Yantasee
Journal:  Cancer Metastasis Rev       Date:  2021-05-07       Impact factor: 9.237

4.  Accumulation of Regulatory T Cells in Triple Negative Breast Cancer Can Boost Immune Disruption.

Authors:  Asmaa M Zahran; Omnia El-Badawy; Lamiaa M Kamel; Amal Rayan; Khalid Rezk; Mona H Abdel-Rahim
Journal:  Cancer Manag Res       Date:  2021-08-03       Impact factor: 3.989

Review 5.  Implications of TGFβ Signaling and CDK Inhibition for the Treatment of Breast Cancer.

Authors:  Joseph T Decker; Jeffrey A Ma; Lonnie D Shea; Jacqueline S Jeruss
Journal:  Cancers (Basel)       Date:  2021-10-25       Impact factor: 6.639

6.  PI3Kδ/γ inhibitor BR101801 extrinsically potentiates effector CD8+ T cell-dependent antitumor immunity and abscopal effect after local irradiation.

Authors:  Yi Na Yoon; Eunju Lee; Young-Ju Kwon; Jeong-An Gim; Tae-Jin Kim; Jae-Sung Kim
Journal:  J Immunother Cancer       Date:  2022-03       Impact factor: 12.469

7.  Prognostic Evaluation of Metastasis-Related Lymphocyte/Monocyte Ratio in Stage Ⅰ-Ⅲ Breast Cancer Receiving Chemotherapy.

Authors:  Zihan Zhang; Qian Lin; Yi Chen; Chenlin Su; Wuye Lin; Daoyu Wei; Litu Zhang; Haizhou Liu
Journal:  Front Oncol       Date:  2022-03-24       Impact factor: 6.244

8.  CTLA-4 Expression and Its Clinical Significance in Breast Cancer.

Authors:  Rodrigo Kern; Carolina Panis
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2021-06-20       Impact factor: 4.291

Review 9.  Targeting Intercellular Communication in the Bone Microenvironment to Prevent Disseminated Tumor Cell Escape from Dormancy and Bone Metastatic Tumor Growth.

Authors:  Lauren M Kreps; Christina L Addison
Journal:  Int J Mol Sci       Date:  2021-03-13       Impact factor: 5.923

Review 10.  Regulatory T Cells: Barriers of Immune Infiltration Into the Tumor Microenvironment.

Authors:  Ellen N Scott; Angela M Gocher; Creg J Workman; Dario A A Vignali
Journal:  Front Immunol       Date:  2021-06-10       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.